Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study
NCT ID: NCT07184125
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
124 participants
OBSERVATIONAL
2024-08-30
2025-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Dexmedetomidine Infusion on Post Anesthesia Discharge Time
NCT07180810
Comparison of Pharmacological and Non-Pharmacological Interventions For Alleviating Preoperative Anxiety In Children
NCT05469412
Assessing the Effectiveness of Midazolam Premedication
NCT03325335
Propofol vs. Nasal Dexmedetomidine in Pediatric Agitation and Delirium
NCT06466915
Effect of Midazolam Premedication on Opioid-induced Mask Ventilation Difficulty
NCT05369819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 group will be given Midazolam
2nd group will be given normal saline
To measure anxiolysis, satisfaction level of patient after receiving Midazolam
Anxiety \& satisfaction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
To measure anxiolysis, satisfaction level of patient after receiving Midazolam
Anxiety \& satisfaction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ASA I-II
Exclusion Criteria
2. Pregnancy
3. Allergy to Midazolam,
4. Patient with diagnosed psychosis,
5. Chronic kidney disease.
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaukat Khanum Memorial Cancer Hospital & Research Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Mehwish Shafique, MBBS, FCPS Anesthesia
Role: PRINCIPAL_INVESTIGATOR
Shaukat Khanam Cancer Memorial Hospital & Research Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shaukat Khanam Cancer Memorial Hospital Lahore
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-23-27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.